+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prediction of relapse from complete remission in diffuse large cell lymphoma



Prediction of relapse from complete remission in diffuse large cell lymphoma



Proceedings of the American Association for Cancer Research Annual Meeting 32: 190




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032907518

Download citation: RISBibTeXText


Related references

Relapse from complete remission more than 5 years after therapy for diffuse large B-cell lymphoma. (DLBCL): Relapse histology most commonly DLBCL with a germinal center B-cell (GCB) phenotype. 2007

The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission. Biology of Blood and Marrow Transplantation 13(4): 486-492, 2007

Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma. Archivum Immunologiae et Therapiae Experimentalis 61(2): 165-174, 2013

Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy. Leukemia and Lymphoma 53(10): 1949-1952, 2013

Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: Natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. Annals of Oncology 8(11): 1125-1132, 1997

Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. Annals of Oncology 8(11): 1125-1132, 1998

Cardiac Recurrence of Diffuse Large B-cell Lymphoma More Than a Decade After Attaining Complete Remission. American Journal of Case Reports 19: 1057-1062, 2018

Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy. Chinese Journal of Cancer 34(2): 70-78, 2015

Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma. Haematologica 85(4): 437-438, 2000

Complete remission of diffuse large B-cell lymphoma of the stomach after eradication of Helicobacter pylori. Ugeskrift for Laeger 173(39): 2425-2426, 2011

Adaptive B cell responses in rituximab-treated diffuse large B cell lymphoma patients during complete remission. Tumour Biology 37(1): 829-835, 2017

Combined immunoradiotherapy induces long-term remission of CNS relapse of peripheral, diffuse, large-cell lymphoma after allogeneic stem cell transplantation: case study. Neuro-Oncology 7(4): 508-510, 2005

Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma. Nouvelle Revue Francaise d'Hematologie 31(4): 315-316, 1989

Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections. Clinical Lymphoma, Myeloma and Leukemia 12(6): 455-458, 2013

Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab. Journal of Dermatology 33(5): 377-379, 2006